-
Queen’s University Belfast and Domainex Win Late-Stage Award to Progress Novel Lung Cancer Drug Candidate into the Clinic
Queen’s University Belfast and Domainex Ltd secure funding from the Wellcome Trust to accelerate early development of first-in-class FLIP inhibitors.
-
Synpromics Further Strengthens Board and Management Team
Synpromics appoints Dr John Shields as Investor Director and Dr Ken Macnamara as Director of Operations.
-
Johnson Matthey and Domainex Collaborate to Enhance Discovery and Development Services for UK Pharma, Biotech and Academia
Johnson Matthey and Domainex have announced a collaboration to provide integrated small molecule pharmaceutical discovery and development services.
-
The RSA Group to Open New US HQ in Kendall Sq, Boston and Extend Facilities in London
The RSA Group, the world’s largest Talent Consultancy in Life Science, is extending its US operation with a new office in Kendall Square, at the heart of the largest biotech cluster in the USA.
-
Dow AgroSciences and TeselaGen Advance Biodesign Technologies for Agriculture
Dow AgroSciences and TeselaGen announce collaboration to produce biological design automation platform.
-
Twist Bioscience Acquires Genome Compiler To Add Gene Design Capabilites
Twist Biosciences announces acquisition of Genome Compiler Corporation.
-
UK’s First Commercial Synthetic Biology Foundry Goes Into Production
New facility for engineering biology enables DNA synthesis, assembly and verification.
-
Bento Lab – The DNA Laboratory for Everybody – Concludes Beta Testing
London, UK, 23rd March 2016 / Sciad Newswire / Bento Lab, the first affordable DNA laboratory, has successfully concluded its beta-testing and is now preparing to fund its first production run. As well as seeking funding from traditional sources, Bento Lab is launching a Kickstarter campaign to fund the production run – giving people the chance to conduct experiments at home or in…
-
Cypralis Limited Announces Appointment of Dr Michael Peel as Chief Scientific Officer
Cypralis appoints Dr Michael Peel as Chief Scientific Officer.
-
UK Strategic Plan for Synthetic Biology 2016 Released
Minister for Life Sciences George Freeman MP will today visit SynbiCITE at Imperial College London, the UK innovation and knowledge centre for synthetic biology, to announce the release of the UK Synthetic Biology Strategic Plan 2016 — Biodesign for the Bioeconomy.